Clinical Trial Update: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing two YUTIQ implants to sham for chronic non-infectious intraocular inflammation of the posterior segment; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis
• Intermediate Uveitis
• Posterior Uveitis
• Uveitis

Drugs mentioned

• YUTIQ (fluocinolone acetonide)

Snippet

Sponsor: Texas Retina Associates | Conditions: Uveitis, Uveitis, Posterior | Phase 3 | Status: RECRUITING